Self-Reported Medication Use and Urinary Drug Metabolites in the German Chronic Kidney Disease (GCKD) Study.

Fruzsina KotsisUlla T SchultheissMatthias Wuttke Pascal SchlosserJohanna MielkeMichael S BeckerPeter J OefnerEdward D Karoly Robert P Mohney Kai Uwe Eckardt Peggy Sekula Anna Kottgennull null

Published in: Journal of the American Society of Nephrology : JASN (2021)

This comprehensive screen of associations between urine drug metabolite levels and self-reported medication use supports the use of pharmacometabolomics to assess medication adherence and prescription patterns in persons with CKD, and indicates under-reported use of medications available over the counter, such as analgesics.

Keyphrases

chronic kidney disease
end stage renal disease
ms ms
adverse drug
drug induced
peritoneal dialysis